Data compiled by Redley Lamar · ChainSifter Intelligence
1Suppliers
4Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Forte Biosciences, Inc. (FBRX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
9Total relationships
3Distinct source URLs
6High confidence
0.831Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Forte Biosciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
CLINICAL-RESEARCH-ORGANIZATION
CLINICAL-RESEARCH-ORGANIZATION
92%
The Company entered into agreements with a clinical research organization ("CRO") for clinical trials of FB102, its product candidate.
Forte Biosciences, Inc. Customers
Ticker
Name
Confidence
Evidence
ARGENX-BV
ARGENX-BV
90%
As part of the Offering, argenx BV has made a strategic investment in the Company.
SNYNF
Sanofi
72%
most significantly China, with respect to trade policies, treaties, tariffs, taxes, and other limitations on cross-border operations. The U.S. government has made and continues to make significant ad…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from FBRX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from FBRX graph: Reciprocal relationship from SNYN…
LEGAL-PROCEEDINGS-FORTE-BIOSCIENCES-INC
LEGAL-PROCEEDINGS-FORTE-BIOSCIENCES-INC
62%
vable, or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for in…
Forte Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
FBRX-DEBT
Debt stack $22.1M
90%
Market cache reports total debt of $22.1M.
FBRX-DEBT-9444
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
FBRX-DEBT-9443
Warrants outstanding: 479000
90%
xbrl warrant detail from xbrl 2025-06-30.
Forte Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Forte Biosciences, Inc..
Forte Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
FBRX-OWNER-JANUS-HENDERSON-GROUP-PLC
JANUS HENDERSON GROUP PLC
90%
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 70 tracked holders.
Forte Biosciences, Inc. Extended Supply Chain Network
